Skip to main content
logo
vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · Real-Time Price · USD
33.92
+1.68 (5.21%)
At close: Jun 17, 2026, 4:00 PM EDT
33.25
-0.67 (-1.98%)
After-hours: Jun 17, 2026, 5:00 PM EDT

vTv Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
36.84-1.02-2.024.01
Revenue Growth (YoY)
216600.00%----49.61%-37.56%
Gross Profit
36.84-1.02-2.024.01
Selling, General & Admin
15.8714.9513.6511.9112.212.34
Research & Development
24.0117.8611.5513.612.3613.32
Total Operating Expenses
39.8832.8125.225.524.5625.67
Operating Income
-3.04-32.81-24.18-25.5-22.54-21.66
Interest Income
2.381.871.570.470.350
Interest Expense
-0.01-0.01--0.01-0.02-0.01
Other Non-Operating Income (Expense)
-0.11-0.140.01-0.92-2.674.06
Total Non-Operating Income (Expense)
2.271.731.58-0.46-2.334.05
Pretax Income
-0.73-31.08-22.61-25.97-24.87-17.62
Provision for Income Taxes
--0.1-0.20.12
Net Income
-0.73-31.08-22.71-25.97-25.07-17.73
Minority Interest in Earnings
-2.98-4.11-4.24-5.72-5.91-4.74
Net Income to Common
2.25-26.97-18.46-20.25-19.16-12.99
Shares Outstanding (Basic)
1086222
Shares Outstanding (Diluted)
1086222
Shares Change (YoY)
66.57%45.96%176.79%8.60%22.58%32.90%
EPS (Basic)
-0.64-3.20-3.20-9.71-9.98-8.29
EPS (Diluted)
-0.93-3.20-3.20-9.71-9.98-8.29
Free Cash Flow
-10.41-25.26-25.31-19.08-16.04-19.31
Free Cash Flow Per Share
-1.00-3.00-4.39-9.15-8.36-12.33
Gross Margin
100.00%-100.00%-100.00%100.00%
Operating Margin
-8.26%--2377.58%--1116.95%-540.87%
Profit Margin
-1.98%--2232.55%--1242.47%-442.72%
FCF Margin
-28.27%--2488.40%--795.00%-482.10%
EBITDA
-3.03-32.79-24.09-25.41-22.45-21.57
EBITDA Margin
-8.24%--2368.83%--1112.39%-538.65%
EBIT
-3.04-32.81-24.18-25.5-22.54-21.66
EBIT Margin
-8.26%--2377.58%--1116.95%-540.87%
Effective Tax Rate
-0.00%-0.44%0.00%-0.80%-0.65%
SEC Filings: 10-K · 10-Q